Imaging in osteoporosis in rheumatic diseases

被引:5
|
作者
Mandl, Peter [1 ]
Kainberger, Franz [2 ]
Hitz, Mette Friberg [3 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Div Neuro & Musculoskeletal Radiol, Dept Radiol & Nucl Med, A-1090 Vienna, Austria
[3] Zealand Univ Hosp, Dept Med, Endocrinol, DK-4600 Koege, Denmark
来源
关键词
Osteoporosis; Rheumatic and musculoskeletal diseases; Dual-energy X-ray absorptiometry; Quantitative ultrasound; Quantitative computed tomography; Arthritis; BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; QUANTITATIVE COMPUTED-TOMOGRAPHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DUAL-PHOTON-ABSORPTIOMETRY; HIGH-RESOLUTION MRI; IN-VIVO; PERIARTICULAR OSTEOPOROSIS; DISTAL RADIUS; ANKYLOSING-SPONDYLITIS;
D O I
10.1016/j.berh.2016.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a common comorbidity of all major rheumatic diseases, and manifests itself both systemically and locally. Systemic bone loss manifests because of several factors, primarily inflammation, immobility, and commonly used medical treatment for rheumatic diseases. Local bone loss manifests as periarticular demineralization and bone erosion due to local release of inflammatory agents and cytokines, which promote bone resorption. All these factors contribute to the phenomenon of arthritis-associated osteoporosis. This review summarized the currently available and used methods that play a role in the diagnosis and monitoring of osteoporosis and in the detection of osteoporotic fractures. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:751 / 765
页数:15
相关论文
共 50 条
  • [21] Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton
    Alanna M. Dubrovsky
    Mie Jin Lim
    Nancy E. Lane
    [J]. Calcified Tissue International, 2018, 102 : 607 - 618
  • [22] Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton
    Dubrovsky, Alanna M.
    Lim, Mie Jin
    Lane, Nancy E.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2018, 102 (05) : 607 - 618
  • [23] Osteoporosis in inflammatory rheumatic diseases - Prevention and treatment
    Haugberg, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 4 - 5
  • [24] Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases
    Kaneko, Kaichi
    Shikano, Kotaro
    Kawazoe, Mai
    Kawai, Shinichi
    Nanki, Toshihiro
    [J]. INTERNAL MEDICINE, 2022, 61 (16) : 2405 - 2415
  • [25] Peculiarities of course of osteoporosis accompanied with the rheumatic diseases
    Kilasonia, L.
    Kartvelishvili, E.
    Mgaloblishvili, M.
    Skhiereli, M.
    Kirvalidze, N.
    Ganugrava, N.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S41 - S42
  • [26] Glucocorticoid-induced osteoporosis in rheumatic diseases
    Rodrigues Pereira, Rosa Maria
    de Carvalho, Jozelio Freire
    Canalis, Ernesto
    [J]. CLINICS, 2010, 65 (11) : 1197 - 1205
  • [27] Osteoporosis in childhood rheumatic diseases: prevention and therapy
    Cimaz, R
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (03): : 397 - 409
  • [28] MANAGEMENT OF OSTEOPOROSIS IN THE CONTEXT OF AUTOIMMUNE RHEUMATIC DISEASES
    Dionyssiotis, Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S102 - S103
  • [29] Molecular Mechanisms of Osteoporosis in Inflammatory Rheumatic Diseases
    Neumann, E.
    [J]. AKTUELLE RHEUMATOLOGIE, 2012, 37 (04) : 254 - 259
  • [30] OSTEOPOROSIS AND FRACTURES IN PATIENTS WITH RHEUMATIC INFLAMMATORY DISEASES
    Gladkova, E. G.
    Kozhemyakina, E. K.
    Lesnyak, O. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S206 - S207